Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Solid Tumors × spartalizumab × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumors 1 Carcinoma, Renal Cell 1 Carcinoma, Hepatocellular 1

Interventions

spartalizumab 1 selicrelumab 1 fludarabine 1 Sunitinib 1 Sirolimus 1 Interleukin-2 1 Cyclophosphamide 1 Albumin-Bound Paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04237649 2025-05-18

KAZ954 Alone and With PDR001, NZV930 and NIR178 in Advanced Solid Tumors

Novartis

Phase EARLY_PHASE1 Terminated

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡